Global Non-vascular Stents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Non-vascular Stents Market is presumed to reach the market size of nearly USD 3.29 BN by 2030 from USD 1.95 BN in 2022 with a CAGR of 6.8% under the study period 2023 - 2030.

Non-vascular stents are medical devices that are used to treat various conditions in the gastrointestinal (GI) tract, respiratory tract, and urinary tract. These stents are typically made of metal or plastic, and are designed to hold open a narrow or blocked passage in the body.

Market Dynamics:

Chronic diseases (cancer, chronic obstructive pulmonary disease (COPD), and gastrointestinal disorders) are on the rise globally. Non-vascular stents are an important medical device used to treat these conditions, which is expected to drive the growth of the non-vascular stents market. The development of new and advanced stent designs, such as fully covered and biodegradable stents, has led to increased adoption of non-vascular stents. These stents offer improved efficacy and safety compared to traditional stent designs, leading to increased demand for non-vascular stents. Non-vascular stents are typically placed using minimally invasive procedures, such as endoscopy or bronchoscopy, which offer several advantages over traditional surgical procedures. The aging population is at higher risk for developing chronic diseases, such as cancer and COPD, which are commonly treated with non-vascular stents. The increase in aging population is expected to drive the demand for non-vascular stents in the coming years. The reimbursement policies for non-vascular stents vary by country and healthcare system. The availability of reimbursement for non-vascular stent procedures can influence the adoption of these devices and drive the growth of the non-vascular stents market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of non-vascular stents. The growth and trends of non-vascular stents industry provide a holistic approach to this study.

Market Segmentation:

This section of the non-vascular stents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Gastrointestinal Stents (Biliary, Duodenal, Colonic, Pancreatic, Esophageal Stents)
Pulmonary (Airway) Stents (Silicone Airway, Metallic Airway)
Urological Stents
Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Non-vascular Stents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the non-vascular stents market include Medtronic; C. R. Bard, Inc.; Boston Scientific Corporation; ELLA - CS, s.r.o.; CONMED Corporation; HOBBS MEDICAL, INC; Cook Medical; Taewoong Medical Co., Ltd.; Synchron Med Inc.; Glaukos Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Product Code: VMR112111087

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . NON-VASCULAR STENTS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL NON-VASCULAR STENTS MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Gastrointestinal Stents (Biliary, Duodenal, Colonic, Pancreatic, Esophageal Stents) Historic and Forecast Sales by Regions
5.5 Pulmonary (Airway) Stents (Silicone Airway, Metallic Airway) Historic and Forecast Sales by Regions
5.6 Urological Stents Historic and Forecast Sales by Regions
5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL NON-VASCULAR STENTS MARKET ANALYSIS BY GEOGRAPHY

6.1. Regional Outlook
6.2. Introduction
6.3. North America Sales Analysis
- 6.3.1. Overview, Historic and Forecast Data Sales Analysis
- 6.3.2. North America By Segment Sales Analysis
- 6.3.3. North America By Country Sales Analysis
- 6.3.4. United State Sales Analysis
- 6.3.5. Canada Sales Analysis
- 6.3.6. Mexico Sales Analysis
6.4. Europe Sales Analysis
- 6.4.1. Overview, Historic and Forecast Data Sales Analysis
- 6.4.2. Europe by Segment Sales Analysis
- 6.4.3. Europe by Country Sales Analysis
- 6.4.4. United Kingdom Sales Analysis
- 6.4.5. France Sales Analysis
- 6.4.6. Germany Sales Analysis
- 6.4.7. Italy Sales Analysis
- 6.4.8. Russia Sales Analysis
- 6.4.9. Rest Of Europe Sales Analysis
6.5. Asia Pacific Sales Analysis
- 6.5.1. Overview, Historic and Forecast Data Sales Analysis
- 6.5.2. Asia Pacific by Segment Sales Analysis
- 6.5.3. Asia Pacific by Country Sales Analysis
- 6.5.4. China Sales Analysis
- 6.5.5. India Sales Analysis
- 6.5.6. Japan Sales Analysis
- 6.5.7. South Korea Sales Analysis
- 6.5.8. Australia Sales Analysis
- 6.5.9. Rest Of Asia Pacific Sales Analysis
6.6. Latin America Sales Analysis
- 6.6.1. Overview, Historic and Forecast Data Sales Analysis
- 6.6.2. Latin America by Segment Sales Analysis
- 6.6.3. Latin America by Country Sales Analysis
- 6.6.4. Brazil Sales Analysis
- 6.6.5. Argentina Sales Analysis
- 6.6.6. Peru Sales Analysis
- 6.6.7. Chile Sales Analysis
- 6.6.8. Rest of Latin America Sales Analysis
6.7. Middle East & Africa Sales Analysis
- 6.7.1. Overview, Historic and Forecast Data Sales Analysis
- 6.7.2. Middle East & Africa by Segment Sales Analysis
- 6.7.3. Middle East & Africa by Country Sales Analysis
- 6.7.4. Saudi Arabia Sales Analysis
- 6.7.5. UAE Sales Analysis
- 6.7.6. Israel Sales Analysis
- 6.7.7. South Africa Sales Analysis
- 6.7.8. Rest Of Middle East And Africa Sales Analysis

7 . COMPETITIVE LANDSCAPE OF THE NON-VASCULAR STENTS COMPANIES

7.1. Non-Vascular Stents Market Competition
7.2. Partnership/Collaboration/Agreement
7.3. Merger And Acquisitions
7.4. New Product Launch
7.5. Other Developments

8 . COMPANY PROFILES OF NON-VASCULAR STENTS INDUSTRY

8.1. Company Share Analysis
8.2. Market Concentration Rate
8.3. Medtronic
- 8.3.1. Company Overview
- 8.3.2. Company Revenue
- 8.3.3. Products
- 8.3.4. Recent Developments
8.4. C. R. Bard Inc.
- 8.4.1. Company Overview
- 8.4.2. Company Revenue
- 8.4.3. Products
- 8.4.4. Recent Developments
8.5. Boston Scientific Corporation
- 8.5.1. Company Overview
- 8.5.2. Company Revenue
- 8.5.3. Products
- 8.5.4. Recent Developments
8.6. ELLA - CS s.r.o.
- 8.6.1. Company Overview
- 8.6.2. Company Revenue
- 8.6.3. Products
- 8.6.4. Recent Developments
8.7. CONMED Corporation
- 8.7.1. Company Overview
- 8.7.2. Company Revenue
- 8.7.3. Products
- 8.7.4. Recent Developments
8.8. HOBBS MEDICAL INC
- 8.8.1. Company Overview
- 8.8.2. Company Revenue
- 8.8.3. Products
- 8.8.4. Recent Developments
8.9. Cook Medical
- 8.9.1. Company Overview
- 8.9.2. Company Revenue
- 8.9.3. Products
- 8.9.4. Recent Developments
8.10. Taewoong Medical Co. Ltd.
- 8.10.1. Company Overview
- 8.10.2. Company Revenue
- 8.10.3. Products
- 8.10.4. Recent Developments
8.11. Synchron Med Inc.
- 8.11.1. Company Overview
- 8.11.2. Company Revenue
- 8.11.3. Products
- 8.11.4. Recent Developments
8.12. Glaukos Corporation
- 8.12.1. Company Overview
- 8.12.2. Company Revenue
- 8.12.3. Products
- 8.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies